Circuit Sport reinvents cycling program
MINNEAPOLIS, Nov. 09, 2021 (GLOBE NEWSWIRE) — Building on 15 years of bringing the best of North American cycling to a global audience, Circuit Sport announces a powerful reimagining of what a racing team can stand for. The new team — and the movement it aims to ignite — will be known as Human Powered Health™.
Human Powered Health will be a wellness platform built to empower people to take control of their own physical and mental well-being. It will spread the message that cultivating healthier habits and living a more active lifestyle can lead to dramatic improvements in health and wellness.
"Human Powered Health represents more than racing, more than athletics," said Charles Aaron, managing director and founder of Circuit Sport. "It's about reminding people that they have more power over their health than they think. We want to support people, mind and body, and use our platform to inspire them to take small, simple steps towards greater health and well-being."
In previous iterations of its teams, Circuit Sport has continually gone beyond the traditional sports marketing model with health and wellness-minded campaigns like Inspired Bikes, Body Positivity, Healthy Habits, and Longevity.
That will expand and evolve as the Human Powered Health platform grows into a hub for health and wellness content with its athletes as the main mouthpiece. New brand partnerships will allow the team to incorporate data analytics across sleep, nutrition, movement, and health care to support its followers on their health journey.
The team will also launch a Discord channel that will serve as a hub for fans, partners, and clients interested in all things Human Powered Health. Hosted by the team and with regular appearances by professional riders, the channel will be a place to share ideas on how to live healthier lifestyles.
Building for the future
Human Powered Health joins the Women's WorldTour in 2022. It is the realization of a dream that began 10 years ago with the formation of the women's program. The move makes Human Powered Health the first co-ed team to send its women to the top division of the sport before its men.
Following a sensational season that included victories in the United Kingdom, Portugal, Denmark, France, and Turkey, the men's program continues in the ProTeam ranks with its sights set firmly on the WorldTour.
"We couldn't take this step without the support of our partners and their shared vision for the future," added Aaron. "We've shown our ability to win bike races around the world but what sustains us is creating connections and empowering people."
Circuit Sport is currently aligning with brands that stand for something bigger than their product, a vital step to building the foundation of Human Powered Health for years to come. These brands, which will be announced in the coming weeks, share the belief that our collective health matters.
In a world navigating a pandemic, and where obesity and heart disease are at all-time highs, there has never been a more important time for each of us to invest in our health and inspire those around us to do the same. Building connections and sharing encouragement and knowledge are pivotal to empowering people to lead healthier lives.
About Circuit Sport
Circuit Sport takes a unique platform approach to sports marketing and management that redefines what a professional cycling team represents. Our teams are more than just a collection of logos on a jersey – we passionately believe that riding a bicycle can improve a person's life. For more information, visit circuitsport.com.
Media contact: Tom Soladay at [email protected]
Circuit Sport reveals Human Powered Health brand and logo
This content was issued through the press release distribution service at Newswire.com.
Human Powered Health
Vaccine stocks were muted Tuesday after test results indicated omicron might elude some of the protection provided by Pfizer's Covid shot.
By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Licensing Agreement with GSK for ARO-HSD; Interim Clinical Data Presented at The Liver Meeting On November 22, 2021, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced a licensing agreement with GlaxoSmithKline (GSK) for ARO-HSD, Arrowhead’s investigational RNAi therapeutic that is currently being evaluated in
Shares of Acadia Pharmaceuticals (NASDAQ: ACAD) rose by as much as 19.2% in premarket trading Tuesday morning. The biotech's stock is taking flight today in response to a positive clinical readout for its experimental Rett syndrome drug known as trofinetide. Rett syndrome is a rare genetic disorder characterized by the progressive degeneration of motor and speech skills.
(Bloomberg) — Former U.S. Secretary of State Rex Tillerson was diagnosed with kidney cancer just months after his infamous 2018 firing via tweet by then-President Donald Trump.Most Read from BloombergThe World’s Relentless Demand for Chips Turns Deadly in MalaysiaSand and Soldiers Mix as Troops Move In to Protect Cancun TouristsEven in the Metaverse, Not All Identities Are Created EqualThe $300 Billion Plan to Bring Green Power to China’s MegacitiesMeet the New Climate Refugee in Town: CoyotesT
Thanks to its highly sensitive tests that can detect cancer earlier, less invasively, and with more confidence than the alternatives, Exact Sciences (NASDAQ: EXAS) has already made a home for itself in the oncology screening market. Its operations are perennially unprofitable, not to mention that its pace of revenue growth is often meandering. Are these blemishes dealbreakers, or are they bumps in the road along the trajectory of a growth stock?
The FDA has raised concerns about one of the company's key pipeline candidates in advance of a crucial meeting.
Shares of Bolt Biotherapeutics (NASDAQ: BOLT) crashed 55.8% on Monday. The steep decline came after the company presented interim data from a phase 1/2 study evaluating BDC-1001 at the European Society for Medical Oncology Immuno-Oncology (ESMO I-O) Congress that's being held virtually this week. Investors were clearly disappointed with Bolt's interim results.
With a few exceptions for emergency or urgent care, Medicare plans will only cover you within the U.S. and its territories. But should you maintain your coverage when you move abroad? Expert Ron Elledge answers some common questions.
Biotech giant Gilead Sciences (NASDAQ: GILD) is a good example. With that in mind, let's look into what's going on with Gilead Sciences right now and whether it is worth purchasing its shares. Gilead Sciences' shares have performed on par with the broader market this year.
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), a clinical-stage immunotherapy company developing novel approaches to harness T cells to treat cancer and to detect and prevent emerging infectious diseases, announced today that it has entered into a major sponsored research collaboration with The Ohio State University ("Ohio State") to further develop BioVaxys' haptenized viral antigen platform to create a broadly reactive pan-sarbecovirus vaccine. This
Shares of Aeglea BioTherapeutics (NASDAQ: AGLE), a clinical-stage biopharmaceutical company, are falling today in response to mixed clinical-trial data. Investors nervous about the future of the company's lead candidate pushed the stock 36.6% lower as of 11:53 a.m. ET on Monday. Aegla BioTherapeutics' lead candidate, pegzilarginase, is an enzyme replacement therapy for patients with an ultra-rare amino-acid metabolism disorder called arginase 1 deficiency.
Health care can be one of the biggest expenses a person faces in retirement. A 65-year-old couple who retired in 2021 can expect to spend $300,000 on health care and medical expenses throughout retirement, according to the annual Fidelity Investments Retiree Health Care Cost Estimate. Despite saving and preparing their entire working lives, many people aren't mentally or financially prepared for the high cost of medical expenses in retirement.
Who is enrolled automatically, what Medicare doesn't cover and when you can get hit by penalties.
VTv Therapeutics Inc. said it reduced its workforce by about 65% as it prioritizes development of diabetes drug TTP399.
The European Commission recently approved Pfizer's Xeljanz to treat patients with ankylosing spondylitis.
Is Pfizer stock a buy after a new Covid variant emerged that could undo its Covid vaccine? Is PFE stock a buy right now?
GlaxoSmithKline is seeking approval for the world's first plant-based vaccine as it scrambles to catch up with rivals in the race to treat the new variants of coronavirus.
Exit International Switzerland has just legalized a new way to die by assisted suicide. The country’s medical review board has authorized the use of the Sarco Suicide Pod, which is a 3-D-printed portable coffin-like capsule with windows that can be transported to a tranquil place for a person’s final moments of life. Conventional assisted-suicide methods have generally involved a chemical substance. Inventor Philip Nitschke of Exit International told the website SwissInfo.ch that his “death pod”
Medicare for All was a hot topic in the 2020 campaign, but it isn’t always well understood, Here are answers to some common questions about Medicare for All.
Position-by-position comparison of Georgia and Michigan